A key question for disorders like SLE or PsA or RA is whether GLP-1 medicines might exert useful weight loss-independent benefits through reduction of inflammation, Drucker told Healio
Although, anecdotally, it is no secret that Mounjaro is already being prescribed to patients without T2D for weight loss and the comorbidity of T2D and obesity blurs the line, once Mounjaro is approved I believe it will begin reducing the average out of pocket costs for these drugs
Findings suggest that the peptide may support vascular adaptation by encouraging the development of new microvascular networks, a process that can improve perfusion in tissues exposed to reduced blood supply
People are suing Novo Nordisk and Eli Lilly and Company due to legal issues surrounding their GLP-1 receptor agonist drugs, with plaintiffs bringing forth substantially similar allegations against both drug manufacturers
Med14 is a subunit in a multi-protein complex called Mediator, which is a well-described general regulator of gene expression throughout the genome